文献速递药物不良反应与药物警戒

口渴与药物:基于WHO药物警戒数据库的研究

Thirst and drugs: A study in the World Health Organization's pharmacovigilance database.
PubMed 文献 · Br J Clin Pharmacol · 2024-04-16

研究利用WHO全球药物警戒数据库Vigibase®,对2000年1月1日至2023年12月31日成人口渴报告进行比例失衡分析,共纳入3186份报告(其中978份为严重报告),以报告比值比(ROR)评估药物暴露与口渴的关联。结果确认了血管加压素拮抗剂(托伐普坦)、锂剂、格列净类、普瑞巴林和抗毒蕈碱药物与口渴的关联,并发现了单胺再摄取抑制剂、奥氮平、泼尼松龙、呋塞米、利巴韦林和羟丁酸钠等新信号。

要点

  • 确认托伐普坦、锂剂、格列净类、普瑞巴林和抗毒蕈碱药与口渴报告相关。
  • 新发现度洛西汀、文拉法辛、西布曲明、奥氮平、泼尼松龙、呋塞米、利巴韦林和羟丁酸钠的口渴信号。
  • 临床应关注上述药物使用者的口渴症状,及时评估并管理。

核心结论

  • 研究首次提供与人类口渴相关的药物列表,包括已确认关联和新的安全信号。

研究设计与样本

  • 基于WHO全球药物警戒数据库Vigibase®的比例失衡分析,纳入2000年1月1日至2023年12月31日成人口渴报告3186份(978份严重),结果以报告比值比(ROR)表示。

主要发现

  • 确认口渴与血管加压素拮抗剂(托伐普坦)、锂剂、格列净类(达格列净、恩格列净)、普瑞巴林和抗毒蕈碱药物(格隆溴铵、奥昔布宁、噻托溴铵)暴露的关联。
  • 发现新的口渴安全信号:单胺再摄取抑制剂(度洛西汀、文拉法辛、西布曲明)、奥氮平、泼尼松龙、呋塞米、利巴韦林和羟丁酸钠。

临床怎么用

  • 临床药师应关注使用托伐普坦、锂剂、格列净类、普瑞巴林、抗毒蕈碱药及新信号药物的患者,监测口渴症状并评估药物相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Thirst is a complex physiological compensatory mechanism but could also be associated with drugs. This association was poorly investigated previously. Using the WHO global pharmacovigilance database, Vigibase®, disproportionality analyses potential associations between exposure to drugs and thirst reports were performed. All reports of thirst in adults between 01/01/2000 and 31/12/2023 were included. Results are expressed as reporting odds ratio (ROR). Analysis of the 3186 reports of thirst (978 'serious') allowed, first, to confirm the association between thirst and exposure to vasopressin antagonists (tolvaptan), lithium, gliflozins (dapagliflozin, empagliflozin), pregabalin and antimuscarinic drugs (glycopyronium, oxybutynin, tiotropium). Second, new safety signals were described with monoamine reuptake inhibitors (antidepressants: duloxetine, venlafaxine; anti-obesity agent: sibutramine), antipsychotic (olanzapine), glucocorticoid (prednisolone), diuretic (furosemide) drugs as well with ribavirin or sodium oxybate. This study is the first to offer a list of drugs associated with thirst in humans.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Montastruc JL. Thirst and drugs: A study in the World Health Organization's pharmacovigilance database. Br J Clin Pharmacol. 2024. PMID: 38627211. doi:10.1111/bcp.16080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。